摘要
目的:探讨摩西2.0钬激光前列腺剜除术(MoLEP)治疗良性前列腺增生(BPH)的临床效果及安全性。方法:选取上海交通大学医学院附属仁济医院泌尿科2021年3月至6月接受手术治疗BPH患者80例,随机数表法分为MoLEP组38例和常规100W钬激光前列腺剜除术(HoLEP)组42例,比较两组患者围手术期指标、术后1月和6月排尿参数国际前列腺症状评分(IPSS)、最大尿流率(Qmax)、排尿后残余尿量(PVR)和并发症情况。结果:MoLEP组相比HoLEP组止血时间[(6.6±1.1)vs.(11.2±2.3)min]、术中[(27.5±7.3)vs.(44.2±9.8)×103ml]及术后[(20.5±5.6)vs.(35.8±10.2)×103ml]膀胱冲洗量减少,差异具有统计学意义(P<0.05)。两组患者术后1月和6月IPSS、Qmax和PVR差异无统计学意义(P>0.05)。术后1月MoLEP组1例出现压力性尿失禁,HoLEP组2例出现压力性尿失禁,随访至术后6月尿失禁症状均能完全缓解。结论:摩西2.0激光前列腺剜除术治疗BPH有良好的止血效果及较高的手术效率,术后尿控好,并发症少,恢复快。
Objective:To evaluate the efficacy and safety of transurethral Moses 2.0 laser enucleation of the prostate(MoLEP)in the treatment of patients with benign prostatic hyperplasia(BPH).Methods:We chose 80 BPH patients from March 2021 to June 2021as research objects.Among them,38 cases in MoLEP group were treated with120W Moses laser,and 42 cases in HoLEP group with 100W holmium laser.Data were compared between the two groups,including operation time,enucleation time,postoperative bladder irrigation time,indwelling catheterization and hospitalization time,urinary incontinence,changes of maximum flow rate(Qmax)international prostate symptom score(IPSS),residual urine volume(PVR)and so on to assess the safety and efficacy of MoLEP for BPH patients.Results:There were significant differences between the two groups in terms of hemostasis time during operation and postoperative bladder flushing volume(P<0.05).There was no significant difference in IPSS,RUV and Qmax at 1 month and 6 months after operation between two groups(P>0.05).There were also no significant differences in ratio of urinary incontinence and urinary parameter.Conclusions:Moses 2.0 laser enucleation of the prostate in the treatment of BPH has good hemostasis effect,high surgical efficiency,fewer complications and fast recovery advantages.
作者
夏盛强
童臻
孙杰
Xia Shengqiang;Tong Zhen;Sun Jie(Department of Urology,Renji Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200127)
出处
《微创泌尿外科杂志》
2022年第1期28-31,共4页
Journal of Minimally Invasive Urology
基金
上海市卫生和计划生育委员会面上项目(201840300)
作者简介
通信作者:孙杰,sunjie@renji.com
